TDMS Study 93021-04 Pathology Tables
NTP Experiment-Test: 93021-04 INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (a) Report: PEIRPT02 Study Type: SUBCHRON 90-DAY DICYCLOHEXYLCARBODIIMIDE Date: 09/02/97 Route: SKIN APPLICATION Time: 10:18:43 13 WEEK SUBCHRONIC Facility: Microbiological Associates Chemical CAS #: 538-75-0 Lock Date: 05/17/95 Cage Range: All Reasons For Removal: All Removal Date Range: All Treatment Groups: Include All a Number of animals examined microscopically at site and number of animals with lesion Page 1 NTP Experiment-Test: 93021-04 INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (a) Report: PEIRPT02 Study Type: SUBCHRON 90-DAY DICYCLOHEXYLCARBODIIMIDE Date: 09/02/97 Route: SKIN APPLICATION Time: 10:18:43 ____________________________________________________________________________________________________________________________________ B6C3F1 MICE FEMALE 0 1.5 3 6.0 12 24.0 MG/KG MG/KG MG/KG MG/KG MG/KG MG/KG ____________________________________________________________________________________________________________________________________ DISPOSITION SUMMARY Animals Initially in Study 10 10 10 10 10 10 Early Deaths Moribund Sacrifice 10 Survivors Terminal Sacrifice 10 9 10 10 10 Accidently Killed 1 Animals Examined Microscopically 10 10 10 10 10 10 ____________________________________________________________________________________________________________________________________ ALIMENTARY SYSTEM None ____________________________________________________________________________________________________________________________________ CARDIOVASCULAR SYSTEM None ____________________________________________________________________________________________________________________________________ ENDOCRINE SYSTEM None ____________________________________________________________________________________________________________________________________ GENERAL BODY SYSTEM None ____________________________________________________________________________________________________________________________________ GENITAL SYSTEM None ____________________________________________________________________________________________________________________________________ HEMATOPOIETIC SYSTEM None ____________________________________________________________________________________________________________________________________ INTEGUMENTARY SYSTEM None ____________________________________________________________________________________________________________________________________ Page 2 NTP Experiment-Test: 93021-04 INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (a) Report: PEIRPT02 Study Type: SUBCHRON 90-DAY DICYCLOHEXYLCARBODIIMIDE Date: 09/02/97 Route: SKIN APPLICATION Time: 10:18:43 ____________________________________________________________________________________________________________________________________ B6C3F1 MICE FEMALE 0 1.5 3 6.0 12 24.0 MG/KG MG/KG MG/KG MG/KG MG/KG MG/KG ____________________________________________________________________________________________________________________________________ MUSCULOSKELETAL SYSTEM None ____________________________________________________________________________________________________________________________________ NERVOUS SYSTEM Brain (10) (10) (10) (10) (10) (10) Lipoma 1 (10%) ____________________________________________________________________________________________________________________________________ RESPIRATORY SYSTEM None ____________________________________________________________________________________________________________________________________ SPECIAL SENSES SYSTEM None ____________________________________________________________________________________________________________________________________ URINARY SYSTEM None Page 3 NTP Experiment-Test: 93021-04 INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (a) Report: PEIRPT02 Study Type: SUBCHRON 90-DAY DICYCLOHEXYLCARBODIIMIDE Date: 09/02/97 Route: SKIN APPLICATION Time: 10:18:43 ____________________________________________________________________________________________________________________________________ B6C3F1 MICE FEMALE 0 1.5 3 6.0 12 24.0 MG/KG MG/KG MG/KG MG/KG MG/KG MG/KG ____________________________________________________________________________________________________________________________________ TUMOR SUMMARY Total Animals with Primary Neoplasms (b) 1 Total Primary Neoplasms 1 Total Animals with Benign Neoplasms 1 Total Benign Neoplasms 1 Total Animals with Malignant Neoplasms Total Malignant Neoplasms Total Animals with Metastatic Neoplasms Total Metastatic Neoplasm Total Animals with Malignant Neoplasms Uncertain Primary Site Total Animals with Neoplasms Uncertain- Benign or Malignant Total Uncertain Neoplasms ____________________________________________________________________________________________________________________________________ a Number of animals examined microscopically at site and number of animals with lesion b Primary tumors: all tumors except metastatic tumors Page 4 NTP Experiment-Test: 93021-04 INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (a) Report: PEIRPT02 Study Type: SUBCHRON 90-DAY DICYCLOHEXYLCARBODIIMIDE Date: 09/02/97 Route: SKIN APPLICATION Time: 10:18:43 ____________________________________________________________________________________________________________________________________ B6C3F1 MICE MALE 0 1.5 3 6.0 12 24.0 MG/KG MG/KG MG/KG MG/KG MG/KG MG/KG ____________________________________________________________________________________________________________________________________ DISPOSITION SUMMARY Animals Initially in Study 10 10 10 10 10 10 Early Deaths Moribund Sacrifice 9 Natural Death 1 Survivors Terminal Sacrifice 9 9 8 10 10 Accidently Killed 1 1 2 Animals Examined Microscopically 10 10 10 10 10 10 ____________________________________________________________________________________________________________________________________ ALIMENTARY SYSTEM None ____________________________________________________________________________________________________________________________________ CARDIOVASCULAR SYSTEM None ____________________________________________________________________________________________________________________________________ ENDOCRINE SYSTEM None ____________________________________________________________________________________________________________________________________ GENERAL BODY SYSTEM None ____________________________________________________________________________________________________________________________________ GENITAL SYSTEM None ____________________________________________________________________________________________________________________________________ HEMATOPOIETIC SYSTEM None ____________________________________________________________________________________________________________________________________ Page 5 NTP Experiment-Test: 93021-04 INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (a) Report: PEIRPT02 Study Type: SUBCHRON 90-DAY DICYCLOHEXYLCARBODIIMIDE Date: 09/02/97 Route: SKIN APPLICATION Time: 10:18:43 ____________________________________________________________________________________________________________________________________ B6C3F1 MICE MALE 0 1.5 3 6.0 12 24.0 MG/KG MG/KG MG/KG MG/KG MG/KG MG/KG ____________________________________________________________________________________________________________________________________ INTEGUMENTARY SYSTEM None ____________________________________________________________________________________________________________________________________ MUSCULOSKELETAL SYSTEM None ____________________________________________________________________________________________________________________________________ NERVOUS SYSTEM None ____________________________________________________________________________________________________________________________________ RESPIRATORY SYSTEM None ____________________________________________________________________________________________________________________________________ SPECIAL SENSES SYSTEM None ____________________________________________________________________________________________________________________________________ URINARY SYSTEM None Page 6 ------------------------------------------------------------ ---------- END OF REPORT ---------- ------------------------------------------------------------